100 related articles for article (PubMed ID: 27842164)
1. The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma.
Avedschmidt SE; Stagner AM; Eagle RC; Harocopos GJ; Dou Y; Rao RC
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6242-6246. PubMed ID: 27842164
[TBL] [Abstract][Full Text] [Related]
2. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.
Khan M; Walters LL; Li Q; Thomas DG; Miller JM; Zhang Q; Sciallis AP; Liu Y; Dlouhy BJ; Fort PE; Archer SM; Demirci H; Dou Y; Rao RC
Lab Invest; 2015 Nov; 95(11):1278-90. PubMed ID: 26280220
[TBL] [Abstract][Full Text] [Related]
3. New insights into the development of infantile intraocular medulloepithelioma.
Jakobiec FA; Trief D; Rashid A; Rose MF; Minckler D; Vanderveen D; Mukai S
Am J Ophthalmol; 2014 Dec; 158(6):1275-1296.e1. PubMed ID: 25174896
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
[TBL] [Abstract][Full Text] [Related]
5. EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer.
Masudo K; Suganuma N; Nakayama H; Oshima T; Rino Y; Iwasaki H; Matsuzu K; Sugino K; Ito K; Kondo T; Nakamura Y; Yoshihara M; Masuda M; Miyagi Y
In Vivo; 2018; 32(1):25-31. PubMed ID: 29275295
[TBL] [Abstract][Full Text] [Related]
6. Malignant non-teratoid medulloepithelioma of ciliary body with retinoblastic differentiation: a case report and review of literature.
Al-Salam S; Algawi K; Alashari M
Neuropathology; 2008 Oct; 28(5):551-6. PubMed ID: 18410270
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma.
Gao L; Antic T; Hyjek E; Gong C; Mueller J; Waxman I; DeMay RM; Reeves W
Cancer Cytopathol; 2013 Nov; 121(11):644-52. PubMed ID: 23674382
[TBL] [Abstract][Full Text] [Related]
8. EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target.
Lin Z; Tang L; Chen S; Zhang W; Lin J; Gao H; Zhang P
Ophthalmic Res; 2023; 66(1):1014-1019. PubMed ID: 37311441
[TBL] [Abstract][Full Text] [Related]
9. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
10. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression.
Karlsson J; Valind A; Jansson C; O'Sullivan MJ; Holmquist Mengelbier L; Gisselsson D
Oncotarget; 2016 Mar; 7(10):11127-36. PubMed ID: 26848979
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of medulloepithelioma: report of four cases and review of the literature.
Sansgiri RK; Wilson M; McCarville MB; Helton KJ
Pediatr Radiol; 2013 Oct; 43(10):1344-56. PubMed ID: 23989751
[TBL] [Abstract][Full Text] [Related]
13. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
[TBL] [Abstract][Full Text] [Related]
14. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
15. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L
Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198
[TBL] [Abstract][Full Text] [Related]
16. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
[TBL] [Abstract][Full Text] [Related]
17. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract][Full Text] [Related]
18. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
[TBL] [Abstract][Full Text] [Related]
20. Primitive neuroectodermal tumor/Ewing sarcoma of the retina.
Grossniklaus HE; Shehata B; Sorensen P; Bergstrom C; Hubbard GB
Arch Pathol Lab Med; 2012 Jul; 136(7):829-31. PubMed ID: 22742557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
